Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
Condition(s):Stargardt Disease; Macular AtrophyLast Updated:May 19, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Stargardt Disease; Macular AtrophyLast Updated:May 19, 2021Completed
Condition(s):Stargardt DiseaseLast Updated:August 3, 2023Completed
Condition(s):Dry Age-related Macular Degeneration; Macular Degeneration; Retinal Disease; Eye Diseases; Retinal Degeneration; Geographic Atrophy; Macular AtrophyLast Updated:January 25, 2024Active, not recruiting
Condition(s):Geographic Atrophy; Age-Related Macular DegenerationLast Updated:June 24, 2022Active, not recruiting
Condition(s):Birdshot Chorioretinopathy; Cystoid Macular Edema; Transient Partial Visual LossLast Updated:January 23, 2013Completed
Condition(s):RetinoschisisLast Updated:November 2, 2023Recruiting
Condition(s):Dry Age-related Macular Degeneration; Macular Degeneration; Retinal Disease; Retinal Degeneration; Geographic Atrophy; Macular AtrophyLast Updated:October 23, 2023Active, not recruiting
Condition(s):Neovascular Age-related Macular Degeneration; Retinal Disease; Retinal Degeneration; Macular DegenerationLast Updated:October 31, 2022Terminated
Condition(s):Age Related Macular DegenerationLast Updated:February 28, 2024Recruiting
Condition(s):Dry Age-related Macular Degeneration; Geographic Atrophy; Retinal Disease; Macular Degeneration; Macular Atrophy; Retinal Degeneration; Eye DiseasesLast Updated:October 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.